These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 9915863

  • 1. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.
    Mittelstadt PR, Ashwell JD.
    J Biol Chem; 1999 Jan 29; 274(5):3222-7. PubMed ID: 9915863
    [Abstract] [Full Text] [Related]

  • 2. Sp1 is the major fasl gene activator in abnormal CD4(-)CD8(-)B220(+) T cells of lpr and gld mice.
    Xiao S, Marshak-Rothstein A, Ju ST.
    Eur J Immunol; 2001 Nov 29; 31(11):3339-48. PubMed ID: 11745351
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand.
    Huber S, Shi C, Budd RC.
    J Virol; 2002 Jul 29; 76(13):6487-94. PubMed ID: 12050361
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells.
    Fields ML, Sokol CL, Eaton-Bassiri A, Seo S, Madaio MP, Erikson J.
    J Immunol; 2001 Aug 15; 167(4):2370-8. PubMed ID: 11490027
    [Abstract] [Full Text] [Related]

  • 14. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
    Priceputu E, Rodrigue I, Chrobak P, Poudrier J, Mak TW, Hanna Z, Hu C, Kay DG, Jolicoeur P.
    J Virol; 2005 May 15; 79(10):6377-91. PubMed ID: 15858021
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter.
    Yang Y, Dong B, Mittelstadt PR, Xiao H, Ashwell JD.
    J Biol Chem; 2002 May 31; 277(22):19482-7. PubMed ID: 11909874
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
    Ettinger R, Panka DJ, Wang JK, Stanger BZ, Ju ST, Marshak-Rothstein A.
    J Immunol; 1995 May 01; 154(9):4302-8. PubMed ID: 7536768
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M, Ganea D.
    J Immunol; 2001 Jan 15; 166(2):1028-40. PubMed ID: 11145682
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.